Clinical Trial Update: Multi-Omics-Based Novel Thrombosis and Bleeding Markers and Risk Model for CHD

View source ↗

Summary

A clinical trial evaluating multi-omics-based markers and a risk model to predict thrombosis and bleeding risk in coronary artery disease; current status is rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Xueyan Zhao | Conditions: Thrombosis, Bleeding | Status: RECRUITING